Naproxen
- Product NDC
- 70518-3514
- 11-digit product format
- 705183514
- Labeler code
- 70518
- Product ID
- 70518-3514_eb687405-008f-51cc-e053-2995a90af22f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Naproxen
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA212517
- Marketing category
- ANDA
- Marketing start
- 2022-09-08
- Marketing end
- 0000-00-00
- Substance
- NAPROXEN
- Active strength
- 250 mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-3514-0 | 70518351400 | 30 TABLET in 1 BLISTER PACK (70518-3514-0) | 30 tablet | 2022-09-08 | 0000-00-00 | No | No | Current |